1. REPORT
2. ESAP METADATE
3. INFORMATION ABOUT THE ENTITY
4. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
POLISH FINANCIAL SUPERVISION AUTHORITY |
|||||||||||
|
UNI - EN REPORT No |
276 | / |
2026 |
|
||||||
Date of issue: |
2026-09-17 |
||||||||||
Short name of the issuer |
|||||||||||
SOPHARMA AD |
|||||||||||
Subject |
|||||||||||
Notification from "Kaliman RT" AD in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD on 16.09.2026 |
|||||||||||
Official market - legal basis |
|||||||||||
Art. 56 ust. 1 pkt 2 Ustawy o ofercie – informacje bieї№ce i okresowe |
|||||||||||
Unofficial market - legal basis |
|||||||||||
Contents of the report: |
|||||||||||
Notification from "Kaliman RT" AD in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD on 16.09.2026 |
|||||||||||
Annexes |
|||||||||||
File |
Description |
||||||||||
Notification from "Kaliman RT" AD in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD on 16.09.2026 |
|||||||||||
Legal framework |
Type of information |
||||
TRANSD |
Managers’ transaction |
||||
RegulatoryData |
|||||
Collection Body |
PLKNF |
||||
Unique data record identifier |
|||||
Type of submission |
New (to be used for new information) |
||||
Voluntary information flag |
|||||
Date or period covered [Date or beginning of the period to which the information relates] |
2026-09-16 |
||||
Date or period covered [Date or end of the period to which the information relates] |
2026-09-16 |
||||
Personal data flag |
|||||
Macierzyste państwo członkowskie, w stosownych przypadkach |
PL |
||||
DocumentReference |
|||||
Język, w którym przekazano informacje |
Oryginał (ORIG) czy tłumaczenie (TRAN) |
Numer referencyjny pliku danych |
|||
PL |
ORIG |
||||
SubmittingEntity |
|||||
Submitting entity LEI |
or |
Submitting entity name - natural person |
|||
RelatedEntity/LegalPerson |
|||||
Entity LEI |
Size of the entity |
Industry sector(s) |
|||
097900BGGW0000048796 |
Large undertaking |
(acc. NACE): C |
|||
SOPHARMA AD |
|||||||||||||
(fullname of the issuer) |
|||||||||||||
SOPHARMA AD |
Farmaceutyczny (far) |
||||||||||||
(short name of the issuer) |
(sector according to clasification of the WSE in Warsow) |
||||||||||||
1220 |
Sofia |
||||||||||||
(post code) |
(city) |
||||||||||||
IlienskoShosse |
16 | ||||||||||||
(street) |
(number) |
||||||||||||
+359 2 813 42 00 |
+359 2 936 02 86 |
||||||||||||
(phone number) |
(fax) |
||||||||||||
(e-mail) |
(web site) |
||||||||||||
nd |
|||||||||||||
(NIP) |
(REGON) |
||||||||||||
SIGNATURE OF PERSONS REPRESENTING THE COMPANY |
|||||
Date |
Name |
Position / Function |
Signature |
||
2026-09-17 |
Ognian Ivanov Donev |
Executive Director |
|||
